STANDARD BIOTOOLS director granted RSUs and options
STANDARD BIOTOOLS INC. director Kathy L. Hibbs reported equity awards that increase her stake in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
STANDARD BIOTOOLS INC. director Kathy L. Hibbs reported equity awards that increase her stake in the company. On June 18, 2026, she received 99,116 shares of Common Stock as Restricted Stock Units that vest in full on the earlier of June 18, 2027 and one day prior to the next annual stockholders’ meeting, subject to continued service.
She also received a stock option for 175,923 shares of Common Stock at an exercise price of $0.8297 per share, becoming exercisable in twelve equal monthly installments beginning on July 18, 2026, also subject to continued service. After these awards, she directly owns 236,836 shares plus 175,923 stock options.
Insider Trade Summary
Grant/Award: 275,039 shares
Grant/Award
2 txns
Insider
HIBBS KATHY L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to buy) | 175,923 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 99,116 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to buy) — 175,923 contracts (Direct);
Common Stock — 236,836 shares (Direct)
Footnotes (2)
- F1. Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.
- F2. The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
RSU grant size: 99,116 shares
Option grant size: 175,923 options
Option exercise price: $0.8297 per share
+4 more
7 metrics
RSU grant size
99,116 shares
Restricted Stock Units vesting by June 18, 2027 or before next annual meeting
Option grant size
175,923 options
Stock Option (Right to buy) granted June 18, 2026
Option exercise price
$0.8297 per share
Exercise price for 175,923 stock options
Shares after award
236,836 shares
Total Common Stock directly owned after RSU grant
Underlying option shares
175,923 shares
Common Stock underlying stock option award
Option expiration
June 18, 2036
Expiration date of stock option grant
RSU vesting reference date
June 18, 2027
Latest vesting date for RSUs, subject to earlier annual meeting trigger
Key Terms
Restricted Stock Units ("RSUs"), Stock Option (Right to buy), exercise price, vesting, +1 more
5 terms
Restricted Stock Units ("RSUs") financial
"Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 18, 2027..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to buy) financial
"Stock Option (Right to buy) with 175,923.0000 shares and an exercise price of 0.8297..."
exercise price financial
"conversion_or_exercise_price: "0.8297" for the Stock Option (Right to buy)..."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"RSUs vest in full on the earlier of June 18, 2027 and one day prior to the next annual meeting, subject to continued service..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-06-18T00:00:00.000Z" for the stock option award..."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did STANDARD BIOTOOLS (LAB) director Kathy Hibbs receive in this Form 4?
Kathy Hibbs received stock-based compensation awards, including 99,116 Restricted Stock Units and options for 175,923 shares. These awards increase her direct equity exposure to STANDARD BIOTOOLS, aligning her interests more closely with shareholders through future-vesting stock and stock options.
What are the terms of Kathy Hibbs’ RSU grant at STANDARD BIOTOOLS (LAB)?
The RSU grant covers 99,116 shares that vest in full on the earlier of June 18, 2027 and one day before the next annual stockholders’ meeting, if she remains in service. Each RSU converts into one share of common stock upon vesting.
What are the key details of Kathy Hibbs’ new stock options at STANDARD BIOTOOLS (LAB)?
Hibbs received options on 175,923 shares at $0.8297 per share. These options begin vesting in twelve equal monthly installments starting July 18, 2026, contingent on her continued service, and expire on June 18, 2036 if not exercised.
Does this STANDARD BIOTOOLS (LAB) Form 4 show an insider stock sale?
No, the Form 4 reports equity grants, not open-market sales. All transactions are coded as awards (code A), reflecting compensation-related acquisitions of RSUs and stock options rather than purchases or sales in the market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
